Results 21 to 30 of about 577,451 (225)

Vessel Wall MRI Enhancement in Noninflammatory Cerebral Amyloid Angiopathy [PDF]

open access: yes, 2020
Cerebral amyloid angiopathy is characterized by deposition of amyloid-β fibrils in the walls of small-to-medium-sized blood vessels. In this retrospective review of 5 patients with histologically confirmed noninflammatory cerebral amyloid angiopathy ...
Nael, K   +4 more
core   +1 more source

Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia [PDF]

open access: yes, 2001
Familial British dementia (FBD), pathologically characterized by cerebral amyloid angiopathy (CAA), amyloid plaques, and neurofibrillary degeneration, is associated with a stop codon mutation in the BRI gene resulting in the production of an ...
Tammaryn Lashley   +44 more
core   +1 more source

Cerebral Amyloid Angiopathy and the Fibrinolytic System: Is Plasmin a Therapeutic Target? [PDF]

open access: yes, 2021
Cerebral amyloid angiopathy is a devastating cause of intracerebral hemorrhage for which there is no specific secondary stroke prevention treatment. Here we review the current literature regarding cerebral amyloid angiopathy pathophysiology and treatment,
Werring, DJ   +5 more
core   +1 more source

Cerebral amyloid angiopathy : new insights from transgenic mice [PDF]

open access: yes, 2004
Cerebral amyloid angiopathy (CAA) is characterized by the deposition of congophilic material within the walls of small to medium-sized blood vessels of the brain and leptomeninges.
Herzig, Martin C.
core   +1 more source

Proteomic dysregulation associated with cerebral amyloid angiopathy [PDF]

open access: yesAlzheimers Dement
Abstract INTRODUCTION Cerebral amyloid angiopathy (CAA) is characterized by impaired vascular amyloid‐β clearance, distinct from Alzheimer's disease (AD), underscoring the need to clarify its molecular basis for predicting therapy‐related amyloid‐related imaging abnormalities. METHODS We analyzed post‐mortem brain proteomics from Religious Orders Study
Han S   +8 more
europepmc   +2 more sources

Neurodegeneration and neurogenesis in mouse models of aging and Alzheimer's disease [PDF]

open access: yes, 2003
As the proportion of senior citizens gradually increases, the behavioral changes that occur with normal aging and as a consequence of Alzheimer’s disease (AD) will afflict many of us in the future.
Bondolfi, Luca E.
core   +1 more source

Cerebral Amyloid Angiopathy-Related Inflammation in Iatrogenic Cerebral Amyloid Angiopathy. [PDF]

open access: yesEur J Neurol
ABSTRACTIntroductionCerebral amyloid angiopathy (CAA) related inflammation (CAA‐ri) is considered to be a distinct syndrome caused by an inflammatory response to amyloid‐β deposition in the walls of small leptomeningeal and cortical vessels in patients with sporadic CAA. However, recent data suggest that inflammation might contribute to a broader range
Panteleienko L   +6 more
europepmc   +3 more sources

Cerebral amyloid angiopathy: A case report [PDF]

open access: yes, 2018
Cerebral amyloid angiopathy (CAA) is a cerebrovascular disorder caused by the accumulation of cerebral β amyloid (Aβ) in the media and intima of leptomeningeal and cortical vessels of the brain.
Saini, Bharti
core   +1 more source

Early MRI imaging and follow-up study in cerebral amyloid angiopathy

open access: yesOpen Medicine, 2021
To study the imaging features of leukoaraiosis (LA) and hemorrhage in cerebral amyloid angiopathy (CAA) patients.
Zhang Shan-chun   +8 more
doaj   +1 more source

Cerebral amyloid angiopathy-related inflammation presenting with a stroke-like episode

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2023
Cerebral amyloid angiopathy (CAA) is characterised by B-amyloid deposition in the walls of small to medium sized arteries of the cerebral cortex and the leptomeninges.
Ana Rita Gaspar   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy